Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

FDA Panel Passes First Cancer Vaccine

Prostate treatment recruits immune system to fight tumors

By Heather McPherson, Newser User

Posted Mar 30, 2007 11:20 AM CDT

(Newser) – A cancer drug that's the first to harness the body's immune system to destroy tumors got a thumbs-up from the FDA's advisory panel, the New York Times reports. If approved, Provenge, a prostate cancer treatment, would be the first of the "cancer vaccines"—... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

There are no comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

'Serpent Pastor' Dies of Snake Bite

Oosp: Romney's New App Misspells 'America'

New York Times (Source Grid »)

Dendreon Announces Plans to Submit Application for FDA Approval
Prostate Cancer Research Institute

FDA panel recommends approval for Dendreon's Provenge
Pharma Times

Dendreon Decision Could Mean FDA Shift
Forbes

cancer • FDA • health • prostate cancer • cancer vaccine • vaccine • Provenge

More Newser Stories

Conservatives Wield FDA Data on HPV Vaccine

Cite health risks in opposing vaccination of teenage girls

(NEWSER) - A group of religious conservatives has marshalled unreleased FDA data as a weapon in the battle against Gardasil, the new cervical cancer vaccine. The data indicates health problems in women taking the vaccine, but drugmaker Merck and the FDA both insist that the negative effects are probably unrelated to the vaccine. Critics oppose legislation to require administering the vaccine in schools. More»

Vaccine May Not Prevent Cervical Cancer

Mandated for all girls in some states, HPV vaccine fails to deliver

(NEWSER) - Pharma behemoth Merck is defending what it touted as a miracle cervical-cancer vaccine against charges of ineffectiveness. Merck lobbied states to mandate Gardasil for young girls—Texas and Virginia did—and got a glowing endorsement from the CDC. But new studies show that it works only to prevent sexually-transmitted HPV, a cause of cancerous cervical growths, not the cancer itself. More»

Coke Modifies Coloring to Avoid Cancer Label

California cracks down on substance in caramel additive

(NEWSER) - Coca-Cola has begun switching to a new caramel coloring—it won't be a noticeable change—to avoid being forced to slap cancer warnings on its soda in California. The chemical that delivers the distinctive color includes a substance called 4-methylimidazole, or 4-MI. In 2011, California decreed that certain levels of 4-MI were carcinogenic. Coke could either modify its formula or print the cancer warnings, reports NPR . More»

Consumer Reports Warns of Arsenic in Fruit Juices

It wants FDA to tighten standards

(NEWSER) - Apple juice and grape juice have levels of arsenic that could raise kids' risk of cancer, according to an investigation by Consumer Reports . The study of 88 samples of fruit juice bought in New York, New Jersey, and Connecticut found that 10% had arsenic levels that exceeded standards set for federal drinking water. In addition, 25% exceeded the levels of lead deemed safe for bottled water. More»

FDA Approves Vaccine for Prostate Cancer

Provenge is first immunotherapy to gain approval

(AP) - A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval today, offering an important alternative to more taxing treatments like chemotherapy. Dendreon Corp.'s Provenge vaccine trains the immune system to fight tumors. It's called a "vaccine" even though it treats disease rather than prevents it. It's also costly, at $93,000 a patient. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

FDA Panel Passes First Cancer Vaccine

Prostate treatment recruits immune system to fight tumors

cancer • FDA • health • prostate cancer • cancer vaccine • vaccine • Provenge

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Conservatives Wield FDA Data on HPV Vaccine

Cite health risks in opposing vaccination of teenage girls

Vaccine May Not Prevent Cervical Cancer

Mandated for all girls in some states, HPV vaccine fails to deliver

Coke Modifies Coloring to Avoid Cancer Label

California cracks down on substance in caramel additive

Consumer Reports Warns of Arsenic in Fruit Juices

It wants FDA to tighten standards

FDA Approves Vaccine for Prostate Cancer

Provenge is first immunotherapy to gain approval

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?